JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Published Online First: 31 August 2007. doi:10.1136/jnnp.2007.123323
Journal of Neurology, Neurosurgery, and Psychiatry 2008;79:522-529
Copyright © 2008 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow web only media
Right arrow All Versions of this Article:
jnnp.2007.123323v1
79/5/522    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Klostermann, F
Right arrow Articles by Sappok, T
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klostermann, F
Right arrow Articles by Sappok, T

RESEARCH PAPERS

Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease

F Klostermann1, F Ehlen1, J Vesper2, K Nubel3, M Gross3, F Marzinzik1, G Curio1, T Sappok1

1 Department of Neurology, CBF, Charité – University Medicine Berlin, Berlin, Germany
2 Department of Stereotactic Neurosurgery, University Clinic of Freiburg, Freiburg, Germany
3 Deparment of Audiology and Phoniatrics, CBF, Charité – University Medicine Berlin, Berlin, Germany

Correspondence to:
Dr Fabian Klostermann, PhD, Charité – University Medicine Berlin, Department of Neurology, 12203 Berlin, Germany; fabian.klostermann{at}charite.de

Background: Motor deficits in Parkinson’s disease (PD) are reduced by deep brain stimulation (DBS) of the subthalamic nucleus (STN), but the impact of this therapy on dysarthrophonic problems in PD remains controversial. We therefore aimed to disentangle the effects of STN DBS on the speech skills of long-term treated patients.

Methods: Under continued medication, speech and motor functions of 19 patients with PD with bilateral STN DBS were studied when their therapeutic stimulation was active (STIM-ON) versus switched off (STIM-OFF). Per condition, perceptual speech ratings were given by: (i) the patients themselves, (ii) the treating physician, and (iii) professional speech therapists. Furthermore, single speech parameters were measured with a battery of technical exams in both STIM-ON and STIM-OFF.

Results: STN DBS significantly worsened speech performance according to all perceptual rating methods applied. In contrast, technical measures showed DBS-induced improvements of single speech dimensions affected by the PD-specific motor disorder. These changes occurred independently of the reduction of motor impairment, which was consistently effectuated by STN DBS.

Conclusion: In parallel to the beneficial effects on the motor symptoms of PD, STN DBS reduces designated disease-inherent dysarthrophonic symptoms, such as glottic tremor. However, these actions on speech are predominantly outweighed by the general dysarthrogenic effects of STN DBS, probably based on a decline of complex (eg, prosodic) functions. Thus, stimulation-induced speech impairment should be considered a likely problem in the course of this treatment.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.